We are live on ! Find out more
CLOS

Compagnie Lombard Odier SCmA Portfolio holdings

AUM $9.25B
1-Year Est. Return 27.04%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+27.04%
3 Year Est. Return
+108.78%
5 Year Est. Return
+129.43%
10 Year Est. Return
+503.05%
AUM
$4.54B
AUM Growth
+$649M
Cap. Flow
+$518M
Cap. Flow %
11.42%
Top 10 Hldgs %
36.6%
Holding
700
New
127
Increased
150
Reduced
122
Closed
48

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$36.3M
2
ABT icon
Abbott
ABT
+$23.9M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$21.3M
4
MRNA icon
Moderna
MRNA
+$19.9M
5
EXAS
Exact Sciences
EXAS
+$19.8M

Top Sells

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$43.8M
2
DIS icon
Walt Disney
DIS
+$40.5M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$18.5M
4
AAPL icon
Apple
AAPL
+$18.2M
5
ABBV icon
AbbVie
ABBV
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 22.17%
2 Communication Services 16.63%
3 Technology 16.06%
4 Financials 13.49%
5 Consumer Discretionary 12.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALLO icon
51
Allogene Therapeutics
ALLO
$714M
$18.9M 0.42%
+536,738
New +$18.1M
MET icon
52
MetLife
MET
$61.7B
$18.9M 0.42%
311,321
+23,085
+8% +$1.27M
TXG icon
53
10x Genomics
TXG
$7.42B
$17.9M 0.39%
+98,783
New +$17.1M
NEO icon
54
NeoGenomics
NEO
$2.12B
$17.4M 0.38%
+361,005
New +$18.8M
NTRA icon
55
Natera
NTRA
$45.9B
$16.6M 0.37%
+163,278
New +$17.9M
APLS
56
DELISTED
Apellis Pharmaceuticals
APLS
$16.6M 0.36%
385,795
+382,795
+12,760% +$18.1M
FCX icon
57
Freeport-McMoran
FCX
$98.3B
$16.4M 0.36%
496,557
+219,360
+79% +$7.11M
BHVN
58
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$16M 0.35%
+234,498
New +$19M
TRHC
59
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$15.9M 0.35%
+344,334
New +$16.4M
BKNG icon
60
Booking.com
BKNG
$159B
$15.8M 0.35%
169,850
+24,600
+17% +$2.19M
INFO
61
DELISTED
IHS Markit Ltd. Common Shares
INFO
$15.5M 0.34%
159,843
-10,145
-6% -$928K
IMGN
62
DELISTED
Immunogen Inc
IMGN
$15M 0.33%
+1,849,772
New +$15.1M
NKE icon
63
Nike
NKE
$62.2B
$14.8M 0.33%
111,040
+13,766
+14% +$1.91M
NBIX icon
64
Neurocrine Biosciences
NBIX
$16.7B
$14.6M 0.32%
+149,864
New +$15.7M
GTHX
65
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$14.5M 0.32%
+601,591
New +$14M
PYPL icon
66
PayPal
PYPL
$50.1B
$14M 0.31%
57,705
+13,788
+31% +$3.48M
JNJ icon
67
Johnson & Johnson
JNJ
$626B
$13.6M 0.3%
82,710
+42,286
+105% +$6.84M
DRNA
68
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$13.5M 0.3%
+526,058
New +$13.4M
TWST icon
69
Twist Bioscience
TWST
$7.76B
$13.2M 0.29%
+106,859
New +$16.2M
GRMN
70
Garmin
GRMN
$60.4B
$13.2M 0.29%
100,300
-100
-0.1% -$12.4K
MCD icon
71
McDonald's
MCD
$193B
$13.1M 0.29%
58,531
-3,804
-6% -$814K
NFLX icon
72
Netflix
NFLX
$315B
$13M 0.29%
249,380
+1,950
+0.8% +$103K
MDRX
73
DELISTED
Veradigm Inc. Common Stock
MDRX
$12.6M 0.28%
+839,521
New +$13.4M
MDT icon
74
Medtronic
MDT
$114B
$12.5M 0.28%
105,976
-6,699
-6% -$785K
GDRX icon
75
GoodRx Holdings
GDRX
$1.29B
$12.3M 0.27%
+314,779
New +$14.2M
1 2
3
4 5

Similar funds

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
LCAM
London & Capital Asset Management London, United Kingdom $9.18B AUM 25.04% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Compagnie Lombard Odier SCmA's Q1 2021 Portfolio in Review

As of Q1 2021, Compagnie Lombard Odier SCmA held 700 positions worth $4.54B, up 17% from $3.89B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Compagnie Lombard Odier SCmA deployed $518M of net new capital in Q1 2021, opening 127 new positions and adding to 150 existing holdings. Its largest new stake was Tandem Diabetes Care: 229,001 shares worth $20.2M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 15% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Walt Disney, an estimated $40.5M trimmed.

  • Compagnie Lombard Odier SCmA's largest Q1 2021 buy was Tandem Diabetes Care: 229,001 shares worth $20.2M.
  • Compagnie Lombard Odier SCmA added most to Adobe in Q1 2021, an estimated $36.3M increase.
  • Compagnie Lombard Odier SCmA's biggest Q1 2021 reduction was Walt Disney, cutting an estimated $40.5M.
  • Compagnie Lombard Odier SCmA fully exited Futu Holdings in Q1 2021, selling an estimated $43.8M.
  • Compagnie Lombard Odier SCmA's ten largest holdings make up 37% of its $4.54B portfolio in Q1 2021.
  • Compagnie Lombard Odier SCmA opened 127 new positions and closed 48 in Q1 2021.
  • Compagnie Lombard Odier SCmA's portfolio value rose 17% quarter-over-quarter to $4.54B.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2021, filed 23 Apr 2021.